Clinical Study of 12-week Trehalose Intake in Patients With Fatty Liver

Updated 06/21/2024

Status Completed

Clinical Trial Summary

This clinical study will be conducted to evaluate the efficacy and safety of trehalose in patients with fatty liver disease. After 12-week intake, subjects will be checked up fat content in liver using CT scan.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Fatty Liver
Liver Diseases
Non-alcoholic Fatty Liver
Non-alcoholic Fatty Liver Disease

Clinical Trial Details

NCT number	NCT03738358
Study type	Interventional
Source	Samsung Medical Center
Contact
Status	Completed
Phase	N/A
Start date	June 30, 2016
Completion date	March 20, 2018

See also
	Status	Clinical Trial	Phase
	Completed	`NCT05485714` - Non-invasive Prediction of Esophageal Varices in Patients With Non-Alcoholic Fatty Liver Disease With Advanced Fibrosis
	Recruiting	`NCT04302051` - Assessment of Fatty Liver With Thermo-acoustic Device
	Recruiting	`NCT04190849` - European Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD)
	Not yet recruiting	`NCT06377631` - Effect of Multi-ingredient on Visceral Adiposity & Non-alcoholic Fatty Liver Disease in Postmenopausal Women With Abdominal Obesity	N/A
	Completed	`NCT03849729` - Effectiveness and Tolerability of Phentermine in Patients Under Bariatric Surgery	Phase 4
	Completed	`NCT04198805` - Vitamin E and DHA-EE on NAFLD - Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial (PUVENAFLD)	Phase 2
	Enrolling by invitation	`NCT04209816` - Genetic Pathways Leading to Fatty Liver and Atherogenic Dyslipidemia
	Terminated	`NCT03953456` - Study to Evaluate the Effect of Elafibranor on Hepatic Lipid Composition in Subjects With Nonalcoholic Fatty Liver (NAFL)	Phase 2
	Active, not recruiting	`NCT01787591` - Dairy Fat as a Mediator of Vitamin E Adequacy in Individuals With Metabolic Syndrome	N/A
	Completed	`NCT05357248` - Nutritional Cognitive Behavioral Therapy Feasibility Study in NAFLD and NASH	N/A